Product NDC: | 0703-0405 |
Proprietary Name: | Levocarnitine |
Non Proprietary Name: | Levocarnitine |
Active Ingredient(s): | 2.5 g/12.5mL & nbsp; Levocarnitine |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0703-0405 |
Labeler Name: | Teva Parenteral Medicines, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA075881 |
Marketing Category: | ANDA |
Start Marketing Date: | 20010601 |
Package NDC: | 0703-0405-02 |
Package Description: | 5 VIAL, SINGLE-DOSE in 1 TRAY (0703-0405-02) > 12.5 mL in 1 VIAL, SINGLE-DOSE (0703-0405-01) |
NDC Code | 0703-0405-02 |
Proprietary Name | Levocarnitine |
Package Description | 5 VIAL, SINGLE-DOSE in 1 TRAY (0703-0405-02) > 12.5 mL in 1 VIAL, SINGLE-DOSE (0703-0405-01) |
Product NDC | 0703-0405 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Levocarnitine |
Dosage Form Name | INJECTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 20010601 |
Marketing Category Name | ANDA |
Labeler Name | Teva Parenteral Medicines, Inc. |
Substance Name | LEVOCARNITINE |
Strength Number | 2.5 |
Strength Unit | g/12.5mL |
Pharmaceutical Classes | Carnitine [Chemical/Ingredient],Carnitine Analog [EPC] |